X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-approval-of-ferriprox-mr-deferiprone-extended-release-tablets-in-canada-301787472.html
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-updated-us-prescribing-information-for-ferriprox-deferiprone-301436934.html
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-approval-of-ferriprox-deferiprone-in-brazil-for-the-treatment-of-iron-overload-in-sickle-cell-disease-301375021.html
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-september-2020
https://www.globenewswire.com/news-release/2020/05/21/2037157/0/en/Chiesi-Group-Receives-FDA-Approval-for-Ferriprox-deferiprone-twice-a-day-tablets.html
https://finance.yahoo.com/news/chiesi-group-receives-fda-approval-144805748.html
https://ml.globenewswire.com/Resource/Download/38892d8a-bb3d-4043-8f6f-11ff20d046f0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208800
https://www.ema.europa.eu/documents/product-information/deferiprone-lipomed-epar-product-information_en.pdf
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004710/smops/Positive/human_smop_001326.jsp&mid=WC0b01ac058001d127
http://twofourinsight.com/patent-challenges-apopharma-ferriprox-akorn-zioptan/
Market Place
Share 
